Taup, Dita P.

HRN: 07-36-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
CEFTRIAXONE 1G (VIAL)
07/03/2024
07/09/2024
IV
2g
OD
UTI
Waiting Final Action 
07/06/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/06/2024
07/06/2024
IV
4.5g
Loading Dose
Septicemia
Waiting Final Action 
07/06/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/06/2024
07/13/2024
IV
2.25g
Q8H
Septicemia
Waiting Final Action 
07/10/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/10/2024
07/10/2024
IVTT
80mg
Stat Dose
IJ Prophylaxis
Waiting Final Action 
07/10/2024
MUPIROCIN 2%, 15G (TUBE)
07/10/2024
07/16/2024
TOPICAL
Apply On Ij Cath Site
Bid
IJ Prophylaxis
Waiting Final Action 
07/11/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/11/2024
07/11/2024
IVTT
80mg
Stat Dose
IJ Prophylaxis
Waiting Final Action 
07/11/2024
CEFUROXIME 750MG (VIAL)
07/11/2024
07/17/2024
IVTT
750 Mg
Q8
UtI , (stepdown)
Rejected 
07/12/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/12/2024
07/12/2024
IVTT
80mg
Stat Dose
IJ Prophylaxis
Waiting Final Action 
07/15/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/15/2024
07/15/2024
IV
80mg
Stat
IJ Prophylaxis
Waiting Final Action 
07/16/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/16/2024
07/23/2024
TOPICAL
Apply On Affected Area
As Needed
Sacral Ulcer
Waiting Final Action 
07/17/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/17/2024
07/17/2024
IV
80 Mg
Once
IJ Cath Prophylaxis
Waiting Final Action 
07/19/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/19/2024
07/19/2024
IV
80mg
STAT
IJ Cath Prophylaxis
Waiting Final Action 
07/24/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/24/2024
07/24/2024
IV
80mg
SD
For Prophylaxis IJ Cath
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: